Thymic stromal lymphopoietin as a therapeutic target for the treatment of eosinophilic esophagitis. Clinical and Translational Gastroenterology. 2026.
Tissue remodeling in eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 2026; 158(2):342-355.
Changing landscape of pediatric eosinophilic gastrointestinal diseases highlighted by updated consensus criteria. Pediatric Allergy and Immunology. 2026; 37(8):e70439.
Penicillin Allergy Decision & Mobile Empowerment (PADME)-Ideation and design of a novel delabeling program for children. Journal of Allergy and Clinical Immunology: In Practice. 2026; 14(5):1192-1195.e3.
Neurological manifestations and vasculopathy in PLCG2–associated antibody deficiency and immune dysregulation (APLAID): a case series. Pediatric Rheumatology. 2026.
IL-13 and calpain-14 suppress the expression of SPINK7 by regulating OVOL1 in eosinophilic esophagitis. JCI Insight. 2026; 11(12).
Single cell atlas of lung-resident innate lymphoid cells shows impact of age and dysbiosis on epigenetic and transcriptomic programming. Mucosal Immunology. 2026; 19(2):1835-1847.
Cendakimab (anti-IL-13) administration improves esophageal gene expression in eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 2026; 157(1):118-130.e7.
Psychosocial Burden of Multiple IgE-Mediated Food Allergies in Pediatric Patients and Caregivers in the FORWARD Study. Nutrients. 2026; 18(11).
Neonatal Inflammatory Skin and Bowel Disease 1 (NISBD1): A Case of ADAM17 Homozygous Mutation. Pediatric Dermatology. 2026; 43(2):378-381.
Longitudinal enrichment of eosinophilic esophagitis in children with AD: The MPAACH cohort. Journal of Allergy and Clinical Immunology. 2026; 157(4):999-1001.
Collaboration as a Catalyst for Advancing Rare Disease Research: The Experience of the Rare Diseases Clinical Research Network. Clinical and Translational Science. 2026; 19(6):e70585.
Eosinophilic Gastrointestinal Disorders Prevention: Insights from Early Life Influences and Atopic Conditions. Journal of Allergy and Clinical Immunology: In Practice. 2026; 14(8):1751-1752.
Tumor necrosis factor-α coordinates the macrophage innate immune response to Histoplasma capsulatum. Infection and Immunity. 2026; e0030226.
Peanut oral immunotherapy at a single academic medical center using a volume-based approach with store-purchased peanut products. Journal of Allergy and Clinical Immunology: Global. 2026; 5(3):100652.
Systematic investigation reveals extensive Epstein-Barr virus transcriptional regulation of the human genome. Cell Genomics. 2026; 6(8):101303.
Factors associated with outgrowing food allergies: Insights from a large food allergy cohort. Annals of Allergy, Asthma and Immunology. 2026.
Non-injectable versus injectable epinephrine treatment thresholds for acute allergic reactions in the community. Journal of Allergy and Clinical Immunology: In Practice. 2026; 14(4):976-980.
Epinephrine and emergency medical services activation recommendations during acute allergic reactions in community settings: International consensus report. Journal of Allergy and Clinical Immunology. 2026; 157(2):429-441.
Recent trends and structural patterns in NIH pediatric research funding, 2015-2024. Pediatric Research. 2026.
B-Cell Repertoire of Children With Atopic Dermatitis Exhibits Altered IgE Maturation Associated With Allergic Food Sensitization. Allergy. European Journal of Allergy and Clinical Immunology. 2026; 81(2):513-523.
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial. The Lancet Gastroenterology and Hepatology. 2026; 11(8):672-688.
Identification of methylation-sensitive human transcription factors using meSMiLE-seq. Nature Communications. 2026; 17(1).
Implementing a Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease in a Diverse Cohort. Genetics in Medicine. 2026; 102662.
O33: An LDL-C polygenic risk score enables early identification of individuals at high risk for hypercholesterolemia who may otherwise be missed. Genetics in Medicine Open. 2026; 4:104320.
The age of eczema onset and multiple food allergies. Annals of Allergy, Asthma and Immunology. 2026; 136(3):340-345.e1.
An expanded codebook of human transcription factor DNA-binding specificity. Nature. 2026; 657(8130):275-283.
GHT-SELEX demonstrates unexpectedly high intrinsic sequence specificity and complex DNA binding of many human transcription factors. Nature Methods. 2026; 23(9):1775-1785.
Gene regulatory network determinants of rapid recall in human memory CD4+ T cells. Cell reports. 2026; 45(4):117103.
Artificial intelligence in the detection and management of eosinophilic gastrointestinal diseases: Applications, challenges, and future outlook. Journal of Allergy and Clinical Immunology. 2026; 157(1):56-58.
Loss of kallikrein 5 expression exacerbates allergic skin inflammation including impairing filaggrin processing, promoting Th2 differentiation and inducing dysbiosis. Mucosal Immunology. 2026; 100404.
Beyond scale in food allergy genetics. Journal of Allergy and Clinical Immunology. 2026; 158(1):46-47.
Sequencing and health data resource of children of African ancestry. Genetics in Medicine. 2026; 28(3):101660.
Return of genome-informed risk-assessment results for common conditions to 23,840 adults and children: An eMERGE network study. American Journal of Human Genetics. 2026; 113(4):678-691.
Eosinophilic gastrointestinal diseases. Nature Reviews Disease Primers. 2026; 12(1).
Dupilumab normalizes the eosinophilic esophagitis disease transcriptome. Journal of Allergy and Clinical Immunology. 2026; 158(2):542-554.
The Electronic Medical Records and Genomics study: Design and analytic framework for assessing the impact of genome-informed risk assessments. American Journal of Human Genetics. 2026; 113(4):664-677.
High-resolution promoter interaction analysis implicates genes involved in activation of type 3 innate lymphoid cells in immune disease risk. Nature Genetics. 2026; 58(8):1953-1966.
Outcomes of Pediatric analgesic allergy challenges and the validation of the I3A tool in four U.S. Cohorts. Journal of Allergy and Clinical Immunology. 2026; 157(2):ab102.
Prevalence and features of eosinophilic gastrointestinal disorders using the large real-world TriNetX database. Journal of Allergy and Clinical Immunology: Global. 2026; 5(5):100762.
A tonsil organoid model reveals Epstein-Barr virus-infected germinal center B cell states during primary infection. Proceedings of the National Academy of Sciences of the United States of America. 2026; 123(33):e2603586123.
Use of the bacterial lysate OM-85 for the primary prevention of wheezing lower respiratory illness in preschool children: a randomised, placebo-controlled trial. The Lancet. 2026; 408(10560):1103-1113.
Additive value of polygenic risk and family history for coronary heart disease risk stratification in two diverse US cohorts. American Journal of Human Genetics. 2026; 113(8):1618-1629.
Polygenic risk score and phenome-wide association study of the Epstein-Barr virus antibody response. Frontiers in Genetics. 2026; 17:1786510.
Paradigms and perspectives: Allergen mRNA therapy for house dust mite allergy. Journal of Allergy and Clinical Immunology. 2026.
Emerging insights into the presentation, pathophysiology, and management of eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 2026; 158(2):331-341.
Maternal Krüppel-like factor 2 (KLF2)+ CD4 T cells promote fertility and fetal tolerance. Proceedings of the National Academy of Sciences of the United States of America. 2026; 123(13):e2519393123.
2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS). Annals of Allergy, Asthma and Immunology. 2026; 136(4):426-493.e1.
Systematic discovery of pathogen effector functions across human pathogens and pathways. Cell. 2026; 189(17):5429-5448.e14.
Food oral immunotherapy patient selection, dosing, and monitoring practices among a network of US food allergy centers. Journal of Allergy and Clinical Immunology: In Practice. 2026.
Extensive binding of poorly characterized human transcription factors to genomic dark matter. Nature Communications. 2026; 17(1).
A Novel Framework for Categorizing Classical Allergy from Multi-Dose Intolerance in Children Undergoing Amoxicillin Challenges. Journal of Allergy and Clinical Immunology. 2026; 157(2):ab106.
Beyond Single-Dose Allergy: Developing Predictive Tools for Multi-Dose Intolerance in Pediatric Amoxicillin Challenges. Journal of Allergy and Clinical Immunology. 2026; 157(2):ab292.
Updates in Pediatric Drug Allergy. Current Allergy and Asthma Reports. 2026; 26(1):11.
Immune functions of the esophagus. Journal of Allergy and Clinical Immunology. 2026; 157(2):316-328.
Antigen-specific messenger RNA lipid nanoparticle therapy with mTOR inhibition promotes regulatory T cells and limits allergy. Journal of Allergy and Clinical Immunology. 2026.
CisBP-RNA: a web resource for eukaryotic RNA-binding proteins and their motifs. Nucleic Acids Research (NAR). 2026; 54(D1):D98-D105.
Eosinophilic gastritis: burden of disease, diagnostic challenges and unmet needs. Gut. 2026.
Functional characterization of viral transcriptional regulators reveals extensive rewiring of host pathways. Nature Communications. 2026.
Emerald Touchless Sensor Quantifies Nighttime Scratching and Sleep Quality in Children With Atopic Dermatitis: PEDISTAD EMERALD Study. Dermatology and Therapy. 2026.
Direct challenges are safe and effective in children with low-risk allergies to oral cephalosporins. Journal of Allergy and Clinical Immunology: In Practice. 2026; 14(1):286-288.e1.
A resource of RNA-binding protein motifs across eukaryotes reveals evolutionary dynamics and gene-regulatory function. Nature Biotechnology. 2026; 44(7):1226-1236.
Glutamine metabolism as a rheostat of CD4+ T cell pathogenic function in metabolic dysfunction-associated steatotic liver disease. Cell Metabolism. 2026.
Peripheral blood markers of pediatric eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 2026; 157(4):1002-1005.
Effects of proton pump inhibitors on remodeling and fibrosis in eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 2026; 157(5):1114-1126.
Genome sequencing and multi-stage, blood-feeding, and tissue-specific transcriptome atlas of the Rocky Mountain wood tick provide a critical resource for this vector. Insect Biochemistry and Molecular Biology. 2026; 195:104646.
Multitrait analysis of genome-wide association studies expands eosinophilic esophagitis genetic susceptibility and polygenic risk scores. Journal of Allergy and Clinical Immunology. 2026; 158(2):492-511.
A highly prevalent lupus risk haplotype increases IRF7-dependent induction of IFN-α, enhancing antiviral defense and exacerbating autoimmunity. American Journal of Human Genetics. 2026.
PTPN13 Contributes to Ebola Virus-Induced Immune Dysregulation via Dephosphorylation of IRF3 and PI3K-p85. Viruses. 2026; 18(7).
Increasing Diagnostic Rate of Pediatric Eosinophilic Gastrointestinal Diseases: A Retrospective Analysis of 18 Years of Experience. Journal of Allergy and Clinical Immunology. 2026; 157(2):ab61.
Peripheral blood markers of eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 2026; 157(2):ab62.